Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism

被引:5
|
作者
Ranganathan, Mohini [1 ,2 ,3 ]
Sewell, R. Andrew [1 ,2 ,3 ]
Carbuto, Michelle [1 ,2 ,3 ]
Elander, Jacqueline [1 ,2 ,3 ]
Schnakenberg, Ashley [1 ,2 ,3 ]
Radhakrishnan, Rajiv [1 ,2 ,3 ]
Pittman, Brian [1 ,3 ]
D'Souza, Deepak Cyril [1 ,2 ,3 ,4 ]
机构
[1] VA Connecticut Healthcare Syst, Schizophrenia & Neuropharmacol Res Grp, West Haven, CT 06516 USA
[2] Connecticut Mental Hlth Ctr, Abraham Ribicoff Res Facil, New Haven, CT 06519 USA
[3] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[4] VA Connecticut Healthcare Syst, Psychiat Serv, West Haven, CT 06516 USA
关键词
Alcohol dependence; Alcohol abuse; CB1R; Cannabinoids; Family history; Vulnerability; RECEPTOR KNOCKOUT MICE; CONDITIONED PLACE PREFERENCE; DOPAMINE D2 RECEPTORS; CANNABINOID CB1; NUCLEUS-ACCUMBENS; ETHANOL-CONSUMPTION; SIGNALING SYSTEM; DEPENDENCE; HISTORY; RATS;
D O I
10.1007/s00213-013-3402-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A family history (FH) of alcoholism accounts for approximately 50 % of the risk of developing alcohol problems. Several lines of preclinical evidence suggest that brain cannabinoid receptor (CB1R) function may mediate the effects of alcohol and risk for developing alcoholism including the observations that reduced CB1R function decreases alcohol-related behaviors and enhanced CB1R function increases them. In this first human study, we probed CB1R function in individuals vulnerable to alcoholism with the exogenous cannabinoid Delta(9)-tetrahydrocannabinol (Delta(9)-THC). Healthy volunteers (n = 30) participated in a three test day study during which they received 0.018 and 0.036 mg/kg of Delta(9)-THC, or placebo intravenously in a randomized, counterbalanced order under double-blind conditions. Primary outcome measures were subjective "high," perceptual alterations, and memory impairment. Secondary outcome measures consisted of stimulatory and depressant subjective effects, attention, spatial memory, executive function, Delta(9)-THC and 11-hydroxy-THC blood levels, and other subjective effects. FH was calculated using the Family Pattern Density method and was used as a continuous variable. Greater FH was correlated with greater "high" and perceptual alterations induced by Delta(9)-THC. This enhanced sensitivity with increasing FH was specific to Delta(9)-THC's rewarding effects and persisted even when FH was calculated using an alternate method. Enhanced sensitivity to the rewarding effects of Delta(9)-THC in high-FH volunteers suggests that alterations in CB1R function might contribute to alcohol misuse vulnerability.
引用
收藏
页码:2385 / 2393
页数:9
相关论文
共 50 条
  • [41] Selective effects Δ9-tetrahydrocannabinol on medium spiny neurons in the striatum
    Fernandez-Cabrera, Monica R.
    Higuera-Matas, Alejandro
    Fernaud-Espinosa, Isabel
    DeFelipe, Javier
    Ambrosio, Emilio
    Miguens, Miguel
    [J]. PLOS ONE, 2018, 13 (07):
  • [42] Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol
    Cerne, Katarina
    [J]. ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY, 2020, 71 (01): : 1 - 11
  • [43] Preformulation Studies of a Prodrug of Δ9-Tetrahydrocannabinol
    Sridhar Thumma
    Soumyajit Majumdar
    Mahmoud A. ElSohly
    Waseem Gul
    Michael A. Repka
    [J]. AAPS PharmSciTech, 2008, 9 : 982 - 990
  • [44] Cannabidiol and (-)Δ9-tetrahydrocannabinol are neuroprotective antioxidants
    Hampson, AJ
    Grimaldi, M
    Axelrod, J
    Wink, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8268 - 8273
  • [45] Urinary pharmacokinetics of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol after controlled oral Δ9-tetrahydrocannabinol administration
    Gustafson, RA
    Kim, I
    Stout, PR
    Klette, KL
    George, MP
    Moolchan, ET
    Levine, B
    Huestis, MA
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (03) : 160 - 167
  • [46] ANTICONVULSANT ACTIVITY OF DELTA 9-TETRAHYDROCANNABINOL
    KARLER, R
    [J]. FEDERATION PROCEEDINGS, 1973, 32 (MAR) : 756 - &
  • [47] Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity
    Dinis-Oliveira, Ricardo Jorge
    [J]. DRUG METABOLISM REVIEWS, 2016, 48 (01) : 80 - 87
  • [48] On the pharmacological properties of Δ9-tetrahydrocannabinol (THC)
    Costa, Barbara
    [J]. CHEMISTRY & BIODIVERSITY, 2007, 4 (08) : 1664 - 1677
  • [49] Modulation of Adipocyte Biology by Δ9-Tetrahydrocannabinol
    Teixeira, Diana
    Pestana, Diogo
    Faria, Ana
    Calhau, Conceicao
    Azevedo, Isabel
    Monteiro, Rosario
    [J]. OBESITY, 2010, 18 (11) : 2077 - 2085
  • [50] SYNTHESIS OF METABOLITES OF DELTA 9-TETRAHYDROCANNABINOL
    PITT, CG
    FOWLER, MS
    SATHE, S
    SRIVASTAVA, SC
    WILLIAMS, DL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1975, 97 (13) : 3798 - 3802